Serum Institute initiates phase 2, 3 clinical study for potential COVID-19 vaccine

New Delhi: Indian pharmaceutical giant Serum Institute of India has initiated the phase 2, 3 clinical trials to evaluate the safety and immune response of coronavirus vaccine candidate on healthy Indian adults after the pharma company got approval from Drugs Controller General of India (DCGI) earlier this month. According to…

Read More Serum Institute initiates phase 2, 3 clinical study for potential COVID-19 vaccine

Coronavirus COVID-19 vaccine astrazeneca oxford university trials conclude mass production early 2021

Image Source : AP/FILE AstraZeneca-Oxford coronavirus vaccine trials to conclude by November, mass production in 2021 The stage 3 clinical trials for the coronavirus vaccine jointly manufactured by the esteemed Oxford University and AstraZeneca will conclude by end of November, an Oxford official has said. The promising data from the…

Read More Coronavirus COVID-19 vaccine astrazeneca oxford university trials conclude mass production early 2021